Clinical and Applied Research Strategies for the Prevention and Control of Fungal Diseases

The summary for the Clinical and Applied Research Strategies for the Prevention and Control of Fungal Diseases grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.

Clinical and Applied Research Strategies for the Prevention and Control of Fungal Diseases: The purpose of this notice of funding opportunity (NOFO) is to support clinical and applied research that will ultimately help reduce illness and death due to fungal diseases around the world caused by both known and emerging pathogens.

Federal Grant Title:	Clinical and Applied Research Strategies for the Prevention and Control of Fungal Diseases
Federal Agency Name:	Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-CK-23-001
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.084
CFDA Descriptions:	Information not provided
Current Application Deadline:	April 28th, 2023
Original Application Deadline:	April 28th, 2023
Posted Date:	February 28th, 2023
Creation Date:	February 28th, 2023
Archive Date:	May 28th, 2023
Total Program Funding:	$7,500,000
Maximum Federal Grant Award:	$1,500,000
Minimum Federal Grant Award:	$1,000,000
Expected Number of Awards:	1
Cost Sharing or Matching:	No
Last Updated:	February 28th, 2023

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: An organization that has a Memorandum of Understanding (MOU) with the Mycoses Study Group (MSG) and functions to be its fiduciary entity is eligible to apply. Proof of such an existing relationship is a required document in the application.
Grant Announcement Contact: Amy Yang
[email protected]
[email protected]
Similar Government Grants: • Modeling Infectious Diseases in Healthcare (MInD Healthcare) to Improve Pathogen Preventio...; • Enhanced Surveillance and Control of Endemic and Emerging Arboviruses in Puerto Rico; • Develop and Test HIV Prevention Interventions for Black and Hispanic Gay, Bisexual, and Ot...; • PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmi...; • NCHHSTP Epidemiologic and Economic Modeling for HIV, Viral Hepatitis, STD, and TB; • Impact of Japanese Encephalitis Vaccination in Cambodia; • Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monk...; • Reduction of Malaria in U.S. Residents Returning from Overseas Travel to Malaria-Endemic C...
More Grants from the Centers for Disease Control and Prevention ERA: • Rigorously Evaluating Primary Prevention Strategies for Intimate Partner Violence and Sexu...; • Formative Research of Community-led Primary Prevention Approaches to Address Elevated Risk...; • Rigorous Evaluation of Primary and Secondary Overdose Prevention Activities Among Populati...; • Effectiveness Research to Prevent Polysubstance-Impaired Driving; • Grants to Support New Investigators in Conducting Research Related to Preventing Interpers...